Biocon Ltd


BSE: 532523 | NSE: BIOCON | ISIN: INE376G01013 
Market Cap: [Rs.Cr.] 5,512 | Face Value: [Rs.] 5
Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

 Discuss this stock

Balance Sheet

(Rs. in Crores)
ParticularsMar-12Mar-11Mar-10Mar-09Mar-08Mar-07
SOURCES OF FUNDS :      
Share Capital 100.00100.00100.00100.0050.0050.00
Reserves Total 1,996.401,846.801,466.291,274.881,278.20891.64
Total Shareholders Funds2,096.401,946.801,566.291,374.881,328.20941.64
Secured Loans 5.6074.0089.68101.4689.2658.73
Unsecured Loans 155.4094.60102.1262.4954.6248.04
Total Debt161.00168.60191.80163.95143.88106.77
Total Liabilities2,257.402,115.401,758.091,538.831,472.081,048.41
APPLICATION OF FUNDS :      
Gross Block 1,212.701,117.301,026.70991.62882.62861.19
Less : Accumulated Depreciation 527.70437.70348.30277.45203.16145.00
Less:Impairment of Assets0.000.000.000.000.000.00
Net Block 685.00679.60678.40714.17679.46716.19
Lease Adjustment0.000.000.000.000.000.00
Capital Work in Progress82.50102.7058.3337.6964.6329.90
Investments 657.00485.90418.64346.69477.2647.02
Current Assets, Loans & Advances      
Inventories 340.40274.70244.80194.52167.74150.66
Sundry Debtors 445.00418.10383.64296.17225.66274.85
Cash and Bank40.00210.3077.126.048.127.63
Loans and Advances 36.1016.00403.07280.28123.5578.51
Total Current Assets861.50919.101,108.63777.01525.07511.65
Less : Current Liabilities and Provisions      
Current Liabilities 314.30250.30381.62219.69166.35175.93
Provisions 148.80128.7083.2576.0068.1640.66
Total Current Liabilities463.10379.00464.87295.69234.51216.59
Net Current Assets398.40540.10643.76481.32290.56295.06
Miscellaneous Expenses not written off 0.000.000.000.000.000.00
Deferred Tax Assets4.003.704.264.053.082.73
Deferred Tax Liability38.9043.3045.3045.0942.9142.49
Net Deferred Tax-34.90-39.60-41.04-41.04-39.83-39.76
Total Assets1,788.001,768.701,758.091,538.831,472.081,048.41
Contingent Liabilities198.10130.50168.40163.24153.54151.43

Peer Comparison

Company Market Cap
(Rs. in Cr.)
P/E (TTM)
(x)
P/BV (TTM)
(x)
EV/EBIDTA
(x)
ROE
(%)
ROCE
(%)
D/E
(x)
Sun Pharma.Inds. 99,536.69 192.62 12.78 27.45 26.1 27.0 0.01
Dr Reddy's Labs 35,691.50 28.20 4.69 18.79 14.3 16.6 0.25
Cipla 30,498.16 20.24 3.44 14.11 15.9 19.8 0.03
Cadila Health. 16,246.12 34.82 5.64 18.45 28.4 24.2 0.40
Glenmark Pharma. 15,472.45 40.08 6.13 23.94 12.7 11.7 0.39
Ranbaxy Labs. 14,984.09 0.00 7.80 72.87 0.0 0.0 2.38
Wockhardt 11,962.85 32.47 14.62 12.82 237.0 30.3 2.09
Piramal Enterp. 9,614.49 0.00 0.91 23.66 0.8 2.1 0.07
Ipca Labs. 8,769.01 26.46 5.59 10.09 24.2 23.7 0.49
Torrent Pharma. 7,166.47 12.43 4.34 11.66 29.6 25.5 0.48
Biocon 5,512.00 19.22 2.50 12.20 12.6 13.6 0.08
Aurobindo Pharma 5,279.46 10.65 1.80 22.89 10.7 8.8 1.01
Strides Arcolab 5,002.13 34.10 3.65 46.94 7.3 8.9 0.56
Mylan Lab. 3,273.19 6.80 1.77 0.00 26.9 26.1 0.59
Alembic Pharma 2,739.85 17.41 5.96 5.60 39.5 27.7 1.07

Futures & Options Quote

 
Expiry Date
276.25 0.10  [0.0]%
Instrument: FUTSTK
Expiry Date: 27 Jun 2013
Open Price: 277.60
Average Price: 275.95
No. of Contracts Traded: 454,000
Open Interest: 1,039,000
Underlying: BIOCON
Market Lot: 1000
Previous Close: 276.25
Day’s High | Low: 279.75 | 274.30
Turnover (Cr.): 12.53
Open Int. Change: -161,000.00 ( [13.4]% )
View detailed F& O quotes >>

Key Information

Key Executives:

Kiran Mazumdar Shaw , Chairman & Managing Director  

John Shaw , Vice Chairman  

Charles L Cooney , Director  

Suresh N Talwar , Director  


Company Head Office / Quarters:
20th KM Hosur Road,
Electronic City,
Bangalore,
Karnataka-560100
Phone : 91-80-28082808/40144014
Fax : 91-80-28523423
E-mail :
co.secretary@biocon.com
investor.relations@biocon.
Web : http://www.biocon.com
Registrars:
Karvy Computershare Pvt Ltd
46
Avenue 4
Street No 1
Banjara Hills
Hyderabad - 500034

Calendar

Jun-2013
M T W T F S S
17 18 19 20 21 22 23
IPO
listNo IPO today
Economic Events
list ANZ Job Advertisements (MoM)
list EIA Natural Gas Storage Change
Results
list Havells India | Union Bank (I) | Dena Bank | Central Bank